Skip to main content

Microbix J(MBX-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Microbix J down on Tuesday (MBX)

Automated Summaries - The Globe and Mail - Tue Apr 9, 4:01PM CDT

In trading today, Microbix J shares closed at $0.36 after opening the day at $0.37. prices ranged from a low of $0.36 to a high of $0.38.

Share prices dipped -2.67% from the previous day's close of $0.38.

During the day across North America, the TSX Composite closed -0.02% at 22260.30, the S&P 500 closed -0.04% at 5202.39, the Dow Jones Industrial Average closed -0.03% at 38892.80 and the Nasdaq Composite closed 0.03% at 16253.96.

Microbix J traded under MBX on the Toronto Stock Exchange (TSX).

A total of 66,886 shares was traded during the last trading day, with total trades of 26. On average, Microbix J has traded 38,690 shares in the last five days and 76,330 year-to-date.

Trading across the entire TSX saw 2,909 price advancers against 2,322 declines and 125 unchanged.

During the prior 52 weeks, MBX.TO has traded as high as $0.47 (May 16,2023) and low as $0.23 (November 10,2023). Moreover, in the last 12 months, Microbix J's shares have dipped -12.05%, while they have dipped -6.41% since the start of 2024.

It announced a 0.28 dividend on August 13/99, with an September 02/99 ex-date and January 01/70 pay day.

Following today's trading, Microbix J has a market capitalization of $51.21 million on a float of 136,550 shares outstanding. Its annual EPS is $0.03.

Microbix J is a None company headquartered in Mississauga, CAN.

Currently, Microbix J has an average recommendation of "Strong Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe